» Articles » PMID: 15688233

Identification of the First Patient with a Confirmed Mutation of the JAK-STAT System

Overview
Journal Pediatr Nephrol
Specialties Nephrology
Pediatrics
Date 2005 Feb 3
PMID 15688233
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Growth hormone insensitivity (GHI) has been attributable, classically, to mutations in the gene for the GH receptor. After binding to the GH receptor, GH initiates signal transduction through a number of pathways, including the JAK-STAT pathway. We describe the first patient reported with a mutation in the gene for STAT5b, a protein critical for the transcriptional regulation of insulin-like growth factor-I.

Citing Articles

Growth Hormone Receptor Regulation in Cancer and Chronic Diseases.

Strous G, Almeida A, Putters J, Schantl J, Sedek M, Slotman J Front Endocrinol (Lausanne). 2020; 11:597573.

PMID: 33312162 PMC: 7708378. DOI: 10.3389/fendo.2020.597573.


"Do We Know Jack" About JAK? A Closer Look at JAK/STAT Signaling Pathway.

Bousoik E, Montazeri Aliabadi H Front Oncol. 2018; 8:287.

PMID: 30109213 PMC: 6079274. DOI: 10.3389/fonc.2018.00287.


JAK2, but not Src family kinases, is required for STAT, ERK, and Akt signaling in response to growth hormone in preadipocytes and hepatoma cells.

Jin H, Lanning N, Carter-Su C Mol Endocrinol. 2008; 22(8):1825-41.

PMID: 18499741 PMC: 2505331. DOI: 10.1210/me.2008-0015.


Recent advances in growth hormone signaling.

Lanning N, Carter-Su C Rev Endocr Metab Disord. 2007; 7(4):225-35.

PMID: 17308965 DOI: 10.1007/s11154-007-9025-5.

References
1.
Godowski P, Leung D, Meacham L, Galgani J, Hellmiss R, KERET R . Characterization of the human growth hormone receptor gene and demonstration of a partial gene deletion in two patients with Laron-type dwarfism. Proc Natl Acad Sci U S A. 1989; 86(20):8083-7. PMC: 298219. DOI: 10.1073/pnas.86.20.8083. View

2.
Rosenfeld R, Hwa V . Toward a molecular basis for idiopathic short stature. J Clin Endocrinol Metab. 2004; 89(3):1066-7. DOI: 10.1210/jc.2004-0092. View

3.
Freeth J, Silva C, Whatmore A, Clayton P . Activation of the signal transducers and activators of transcription signaling pathway by growth hormone (GH) in skin fibroblasts from normal and GH binding protein-positive Laron Syndrome children. Endocrinology. 1998; 139(1):20-8. DOI: 10.1210/endo.139.1.5690. View

4.
Rosenfeld R, Rosenbloom A, Guevara-Aguirre J . Growth hormone (GH) insensitivity due to primary GH receptor deficiency. Endocr Rev. 1994; 15(3):369-90. DOI: 10.1210/edrv-15-3-369. View

5.
Woods K, Fraser N, Postel-Vinay M, Savage M, Clark A . A homozygous splice site mutation affecting the intracellular domain of the growth hormone (GH) receptor resulting in Laron syndrome with elevated GH-binding protein. J Clin Endocrinol Metab. 1996; 81(5):1686-90. DOI: 10.1210/jcem.81.5.8626815. View